estrone has been researched along with Disease Exacerbation in 7 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy, safety and tolerability of letrozole, an advanced non-steroidal aromatase inhibitor, and fadrozole hydrochloride, an older-generation drug in this class, we conducted a randomised double-blind trial in postmenopausal women with advanced breast cancer." | 9.10 | Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer. ( Adachi, I; Ikeda, T; Ohashi, Y; Sasaki, Y; Suwa, T; Tabei, T; Takatsuka, Y; Toi, M; Tominaga, T, 2003) |
| "Serum and urine were collected from 65 breast cancer patients and 36 controls after an overnight fast." | 5.30 | Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. ( Foo, SC; Ho, GH; Ji, CY; Luo, XW; Ng, EH, 1998) |
| "To compare the efficacy, safety and tolerability of letrozole, an advanced non-steroidal aromatase inhibitor, and fadrozole hydrochloride, an older-generation drug in this class, we conducted a randomised double-blind trial in postmenopausal women with advanced breast cancer." | 5.10 | Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer. ( Adachi, I; Ikeda, T; Ohashi, Y; Sasaki, Y; Suwa, T; Tabei, T; Takatsuka, Y; Toi, M; Tominaga, T, 2003) |
| "Serum and urine were collected from 65 breast cancer patients and 36 controls after an overnight fast." | 1.30 | Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. ( Foo, SC; Ho, GH; Ji, CY; Luo, XW; Ng, EH, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Emond, JP | 1 |
| Lacombe, L | 1 |
| Caron, P | 1 |
| Turcotte, V | 1 |
| Simonyan, D | 1 |
| Aprikian, A | 1 |
| Saad, F | 1 |
| Carmel, M | 1 |
| Chevalier, S | 1 |
| Guillemette, C | 1 |
| Lévesque, E | 1 |
| Ho, GH | 1 |
| Luo, XW | 1 |
| Ji, CY | 1 |
| Foo, SC | 1 |
| Ng, EH | 1 |
| Tominaga, T | 1 |
| Adachi, I | 1 |
| Sasaki, Y | 1 |
| Tabei, T | 1 |
| Ikeda, T | 1 |
| Takatsuka, Y | 1 |
| Toi, M | 1 |
| Suwa, T | 1 |
| Ohashi, Y | 1 |
| Karim, R | 1 |
| Hodis, HN | 1 |
| Stanczyk, FZ | 1 |
| Lobo, RA | 1 |
| Mack, WJ | 1 |
| Miller, JG | 1 |
| Gee, J | 1 |
| Price, A | 1 |
| Garbe, C | 1 |
| Wagner, M | 1 |
| Mac Neil, S | 1 |
| Bajetta, E | 1 |
| Zilembo, N | 1 |
| Bichisao, E | 1 |
| Martinetti, A | 1 |
| Buzzoni, R | 1 |
| Pozzi, P | 1 |
| Bidoli, P | 1 |
| Ferrari, L | 1 |
| Celio, L | 1 |
| Oduwole, OO | 1 |
| Isomaa, VV | 1 |
| Nokelainen, PA | 1 |
| Stenbäck, F | 1 |
| Vihko, PT | 1 |
2 trials available for estrone and Disease Exacerbation
| Article | Year |
|---|---|
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
Topics: Administration, Oral; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progres | 2003 |
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.
Topics: Atherosclerosis; Blood Glucose; Carotid Arteries; Cholesterol; Disease Progression; Double-Blind Met | 2008 |
5 other studies available for estrone and Disease Exacerbation
| Article | Year |
|---|---|
Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression.
Topics: Aged; Disease Progression; Estradiol; Humans; Hydroxyestrones; Male; Mass Spectrometry; Middle Aged; | 2021 |
Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
Topics: Age Factors; Anticarcinogenic Agents; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Cell Tra | 1998 |
Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstenedione; Cell Adhesion Molecules; Child; Disease | 1997 |
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors.
Topics: Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; | 2000 |
Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Blotting, Northern; Cells, Cultured; Colonic Neopl | 2002 |